| Coinbase Global (NASDAQ:COIN) is now covered by Raymond James Financial, Inc.. They set a "market perform" rating on the stock. The current price is $170.94. |
| Finance of America Companies (NYSE:FOA) is now covered by Alliance Global Partners. They set a "buy" rating and a $30.00 price target on the stock. This represents a 27.2% upside from the current price of $23.58. |
| Generac (NYSE:GNRC) is now covered by Cantor Fitzgerald. They set an "overweight" rating and a $325.00 price target on the stock. This represents a 51.3% upside from the current price of $214.86. |
| High Roller Technologies (NYSEAMERICAN:ROLR) is now covered by Alliance Global Partners. They set a "buy" rating and a $20.00 price target on the stock. This represents a 182.3% upside from the current price of $7.09. |
| High Tide (NASDAQ:HITI) is now covered by D. Boral Capital. They set a "buy" rating and a $4.00 price target on the stock. This represents a 83.9% upside from the current price of $2.18. |
| Immix Biopharma (NASDAQ:IMMX) is now covered by Needham & Company LLC. They set a "buy" rating and a $21.00 price target on the stock. This represents a 118.3% upside from the current price of $9.62. |
| Imperial Tobacco Group (OTCMKTS:IMBBY) is now covered by BTIG Research. They set a "neutral" rating on the stock. The current price is $38.14. |
| Infleqtion (NYSE:INFQ) is now covered by Craig Hallum. They set a "buy" rating and a $19.00 price target on the stock. This represents a 83.3% upside from the current price of $10.37. |
| Japan Tob (OTCMKTS:JAPAY) is now covered by BTIG Research. They set a "buy" rating on the stock. The current price is $19.69. |
| Nebius Group (NASDAQ:NBIS) is now covered by Robert W. Baird. They set an "outperform" rating and a $250.00 price target on the stock. This represents a 12.9% upside from the current price of $221.41. |
| Nektar Therapeutics (NASDAQ:NKTR) is now covered by Canaccord Genuity Group Inc.. They set a "buy" rating and a $153.00 price target on the stock. This represents a 123.0% upside from the current price of $68.61. |
| Tenax Therapeutics (NASDAQ:TENX) is now covered by Evercore Inc. They set an "outperform" rating and a $39.00 price target on the stock. This represents a 154.7% upside from the current price of $15.32. |